The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19 After Infection and Vaccination
Latest Information Update: 07 Feb 2023
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 08 Aug 2021 Status changed from recruiting to active, no longer recruiting.
- 22 Apr 2021 New trial record
- 16 Apr 2021 Results presented in a Blood Journal the Media Release